🧪 SMART-CHOICE 3 in a Nutshell
🟣 Clopidogrel beat 🟠 aspirin post-PCI:
📉 Fewer MACCE (4.4% vs 6.6%)
🩸 Same bleeding risk
🍽️ Fewer GI events
⚠️ Editorial: Fragile stats, late benefit, open questions on lifelong therapy.
🎯 Verdict: Promising—but not bulletproof.
